Cassel W A, Weidenheim K M, Campbell W G, Murray D R
Cancer. 1986 Apr 1;57(7):1302-12. doi: 10.1002/1097-0142(19860401)57:7<1302::aid-cncr2820570709>3.0.co;2-z.
Five patients with advanced malignant melanoma, treated with viral oncolysate, had solitary central nervous system metastases that were removed surgically. Histologic examination revealed striking and significant mononuclear inflammatory cell infiltrates, consisting of a mean of 60% plasma cells and a lesser proportion of lymphocytes at the edges of the lesions, within their supporting fibrovascular trabeculae, and among the tumor cells. Comparable inflammatory changes were not found in solitary metastatic malignant melanomas removed surgically from the brains of 19 patients not treated with viral oncolysate. Similarly, multiple metastatic malignant melanomas obtained postmortem from the brains of 12 patients not treated with viral oncolysate showed minimal inflammatory responses. Ultrastructural examination of material from a single treated patient revealed morphologic abnormalities of the blood-brain barrier, changes that were perhaps conducive to infiltration of the neoplasm by inflammatory cells. The authors suggest that administration of viral oncolysate enhances the inflammatory cell response to metastatic malignant melanoma in the brain.
五名晚期恶性黑色素瘤患者接受了病毒溶瘤产物治疗,他们有孤立的中枢神经系统转移灶并接受了手术切除。组织学检查显示有显著且明显的单核炎性细胞浸润,在病变边缘、其支持性纤维血管小梁内以及肿瘤细胞之间,平均由60%的浆细胞和较少比例的淋巴细胞组成。在19名未接受病毒溶瘤产物治疗的患者大脑中手术切除的孤立转移性恶性黑色素瘤中未发现类似的炎性变化。同样,从12名未接受病毒溶瘤产物治疗的患者大脑中尸检获得的多发性转移性恶性黑色素瘤显示出最小的炎症反应。对一名接受治疗患者的材料进行超微结构检查发现血脑屏障存在形态学异常,这些变化可能有利于炎性细胞浸润肿瘤。作者认为,给予病毒溶瘤产物可增强大脑中对转移性恶性黑色素瘤的炎性细胞反应。